Innovax ILT
| Species | Chicks. |
|---|---|
| Composition | Each dose (0.2 ml) of reconstituted vaccine contains live cellular recombinant turkey herpesvirus (strain HVT/ILT-138) expressing the glycoproteins gD and gI for infectious laryngotracheitis virus. |
| Indications | For the active immunization of day-old chicks or the immunization of day 18 embryos in vivo, against avian infectious laryngotracheitis (ILT) and Marek's disease (BM). |
| Dosage and method of administration | For the preparation of the vaccine, the frozen suspension and diluent are needed. The preparation of the vaccine must be planned before the vials are removed from the liquid nitrogen in which they are stored, and the exact number of vials and the amount of diluent required must be calculated. When extracting a box of ampoules from the liquid nitrogen container, only the ampoules that will be used immediately are exposed. It is recommended to handle max. 5 ampoules (from one box) at the same time. The ampoules that remain are immediately returned to the container. The contents of the ampoule are rapidly thawed by immersion in clean water at 25-27°C and shaken until completely dispersed. It is important that after thawing the suspension is immediately mixed with the diluent to protect the cells. The ampoule is dried and broken at the level of the neck. The contents are carefully extracted with a sterile syringe equipped with an 18-gauge needle, then through the rubber stopper of the solvent bag it is introduced into it. Shake gently (6-8 turns) to homogenize. Extract some solvent to wash the ampoule and repeatedly inject it into the solvent bag. Use 400 ml of solvent for every 2000 doses of cell suspension for subcutaneous administration and 500 ml of solvent for 10000 doses for in vivo administration. After reconstitution, the vaccine is presented as a transparent, red suspension, which is administered 0.2 ml per chicken, subcutaneously in the neck region or 0.05 ml in the allantoid cavity. It is administered with a simple syringe or automatic syringe. The use of automatic lines for inoculating the vaccine into the embryo is allowed. Before handling, all vaccination equipment is disinfected by boiling for 20 min or by autoclaving (15 min. at 121°C). No chemical disinfectants are used. During vaccination, the container shake frequently to ensure correct vaccine titer. During inoculation, the container is shaken frequently to ensure titer correct vaccine. |
| Contraindications | Vaccination of sick and/or weakened birds is prohibited. |
| Waiting period |
Zero days. |
| Release form | Cell suspension - type 1 ampoules containing 2000 or 4000 doses. Solvent - bags of 400 or 800 ml made of polyethylene or multi-layered plastic. |
| Storage conditions | The cell suspension is stored and transported in liquid nitrogen (-196°C). The ampoule is placed upside down, if the frozen suspension is located at the top of the ampoule, this indicates that the suspension has been thawed and should no longer be used. Solvent at T°C +5 +25°C. After reconstitution - 2 hours at T°C to +25°C. Keep out of the reach of children. |
| Shelf life | Cell suspension - 3 years from the date of production. Solvent in polyethylene bags - 3 years, in multi-layer plastic bags - 2 years. Do not use after the expiry date indicated on the packaging. |